Sunday, September 10, 2006

NIH Slams Scientist's 'Misconduct'

No Disciplinary Action Taken
From the LA Times
Officials at the NIH concluded late last year that the actions of Dr. Thomas J. Walsh, who has helped lead major clinical trials involving cancer patients, might result in dismissal from federal government service. No disciplinary action has been taken.

The internal review, conducted by lawyers and other ethics specialists within the office of the NIH director, found that from 1999 to 2004, Walsh received fees totaling $100,970 from pharmaceutical and biotechnology companies. He accepted fees from 25 companies and has led government-sponsored research involving some of those companies' drugs.

The doctor's lawyers have said the rules were complicated but his intentions were good.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home